(Q41190097)

28 September 2017

title

The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases (English)

1 reference

28 September 2017

1 reference

Li Li

1

1 reference

28 September 2017

Xing Gu

2

1 reference

28 September 2017

Meng Fang

3

1 reference

28 September 2017

Jun Ji

4

1 reference

28 September 2017

Changhong Yi

5

1 reference

28 September 2017

Chunfang Gao

6

1 reference

28 September 2017

publication date

2 June 2015

1 reference

Clinical Chemistry and Laboratory Medicine

28 September 2017

published in

1 reference

28 September 2017

volume

54

1 reference

28 September 2017

issue

4

1 reference

28 September 2017

page(s)

693-701

1 reference

Biomarkers for virus-induced hepatocellular carcinoma (HCC).

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Alteration of adhesion molecule expression and cellular polarity in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Wnt signaling in liver fibrosis: progress, challenges and potential directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

New wrinkles in old receptors: core fucosylation is yet another target to inhibit TGF-β signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

The amazing universe of hepatic microstructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2015-0307

21 January 2018

Identifiers

DOI

10.1515/CCLM-2015-0307

1 reference

28 September 2017

1 reference